Diseases, Conditions, Syndromes

Moderna vaccine confers at least 3 months immunity: study

The Moderna COVID-19 vaccine, which the company says was recently demonstrated to have 94 percent efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed ...

Diseases, Conditions, Syndromes

Potential cholera vaccine target discovered

Findings from a team led by investigators at Massachusetts General Hospital (MGH), reported in the online journal mBio, may help scientists develop a more effective vaccine for cholera, a bacterial disease that causes severe ...

Diseases, Conditions, Syndromes

Antibody evolution may predict COVID-19 outcomes

For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients' antibody development and response, suggests a new Cell paper published by Galit ...

Diseases, Conditions, Syndromes

Children produce different antibodies in response to SARS-CoV-2

Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons ...

page 10 from 40